Neochem Bio Solutions Financials

NSE: NEOCHEM

₹96.10

₹-2.40 (-2.44%)

As on 03-Sep-2026 15:31IST

Market cap

₹169 Cr

Revenue (TTM)

₹84 Cr

P/E Ratio

14

P/B Ratio

2.1

Div. Yield

0 %

Income Statement (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Operating Revenue	84.17	61.15	48.19	--	--	--
Total Income	86.15	62.01	48.79	--	--	--
Total Expenditure	71.06	55.16	43.96	--	--	--
EBITDA	13.11	5.99	4.23	--	--	--
Depreciation	1.33	1.22	1.22	--	--	--
EBIT	11.79	4.77	3.01	--	--	--
Interest	3.51	2.96	2.10	--	--	--
Other Income	1.98	0.86	0.60	--	--	--
Exceptional Items	--	--	--	--	--	--
Profit before Tax	10.26	2.67	1.52	--	--	--
Provision for Tax	2.51	0.87	0.45	--	--	--
Profit after Tax	7.75	1.80	1.07	--	--	--
Minority Interest	--	--	--	--	--	--
Share of Associate	--	--	--	--	--	--
Consolidated Profit	7.75	1.80	1.07	--	--	--

Liabilities (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Shareholder's Funds	19.75	12.00	8.05	--	--	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	15.19	19.12	13.32	--	--	--
Current Liabilities	43.95	32.93	29.23	--	--	--
Total Liabilities	78.89	64.06	50.60	--	--	--

Assets (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Non-Current Assets	25.81	25.37	18.62	--	--	--
Current Assets	53.08	38.69	31.99	--	--	--
Total Assets	78.89	64.06	50.60	--	--	--
Total Debt*	35.62	33.32	26.24	--	--	--
Net Current Assets	9.13	5.75	2.76	--	--	--
Contingent Liabilities	0.07	0.07	--	--	--	--

Cashflow (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Cash From Operating Activities	2.59	1.96	-0.74	--	--	--
Cash Flow from Investing Activities	-1.69	-7.86	-3.35	--	--	--
Cash from Financing Activities	-1.20	6.20	3.76	--	--	--
Net Cash Inflow / Outflow	-0.30	0.30	-0.34	--	--	--

Financials Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Adjusted EPS (₹)	6.64	1.54	1.13	--	--	--
Cash EPS (₹)	7.77	2.59	2.41	--	--	--
Adjusted Book Value (₹)	16.91	10.27	8.48	--	--	--
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	3.89	2.94	-1.37	--	--	--
Free Cash Flow per Share (₹)	-5.40	-10.10	-11.66	--	--	--

Profitability Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
ROCE (%)	27.34	14.15	10.54	--	--	--
ROE (%)	48.82	17.96	13.33	--	--	--
ROA (%)	10.84	3.14	2.12	--	--	--
EBIT Margin (%)	14.00	7.80	6.24	--	--	--
Net Margin (%)	9.00	2.90	2.20	--	--	--
Cash Profit Margin (%)	10.79	4.94	4.75	--	--	--

Growth Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Revenue Growth (%)	37.66	26.89	--	--	--	--
EBIT Growth (%)	147.05	58.54	--	--	--	--
Net Profit Growth (%)	330.28	67.89	--	--	--	--
EPS Growth (%)	330.28	36.48	--	--	--	--
Book Value Growth (%)	64.58	49.07	--	--	--	--

Valuation Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Price / Earnings	--	--	--	--	--	--
Price / Book Value	--	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	2.80	5.79	6.55	--	--	--
Close Price (₹)	--	--	--	--	--	--
High Price (₹)	--	--	--	--	--	--
Low Price (₹)	--	--	--	--	--	--
Market Cap (₹ Cr)	--	--	--	--	--	--

Solvency Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Debt to Equity	1.80	2.78	3.26	--	--	--
Short term debt to equity ratio	1.01	1.16	1.41	--	--	--
Current Ratio	1.21	1.17	1.09	--	--	--
Quick Ratio	0.67	0.62	0.58	--	--	--
Interest Coverage	3.93	1.90	1.72	--	--	--

Operating Efficiency Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Debtors to sales (%)	30.03	28.20	29.91	--	--	--
Asset Turnover	1.18	1.07	0.95	--	--	--
Receivable days	92.18	94.48	109.19	--	--	--
Inventory Days	90.99	98.91	113.09	--	--	--
Payable days	100.44	130.08	156.95	--	--	--
Cash Conversion Cycle	82.73	63.31	65.33	--	--	--